Xtane 25mg Tablet

Breast cancer

Xtane 25mg Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
Swelling of arms and feet
Shortness of breath
Decrease in WBCs
Extreme fatigue
Low mental health
High cholesterol level
Dizziness
Headache
Wheezing
Hair loss
Joint and muscle pain
Trouble sleeping
Seek medical attention in case of any unusual or severe side effects immediately.

The dosage of Xtane 25 mg is prescribed by a doctor based on the cancer stage and the patient’s overall health. This medicine should be taken orally after a meal. Swallow it as a whole. Do not chew, crush, or break it. In case of an overdose, contact your doctor immediately.

Xtane 25 mg belongs to the class of drugs known as aromatase inhibitors. Aromatase is an enzyme that helps in the conversion of androgens to estrogen in post-menopausal women. Estrogen encourages cancer cells to grow uncontrollably. Xtane works by binding to the aromatase enzyme, inhibiting its ability to produce estrogen. This results in a reduction of estrogen levels. Additionally, Xtane not only decreases tumor size but also blocks cell proliferation.

If you forget to take a dose of Xtane 25mg Tablet, consult your doctor. Don’t double up the next dose to cope with the missed one unless your doctor recommends it.​

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1. Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., ... & Richardson, H. (2011). Exemestane for breast-cancer prevention in postmenopausal women. New England Journal of Medicine, 364(25), 2381-2391.
2. Scott, L. J., & Wiseman, L. R. (1999). Exemestane. Drugs, 58(4), 675-680.
3. Deeks, E. D., & Scott, L. J. (2009). Exemestane: a review of its use in postmenopausal women with breast cancer. Drugs, 69(7), 889-918.
4. Di Salle, E., Ornati, G., Giudici, D., Lassus, M., Evans, T. R. J., & Coombes, R. C. (1992). Exemestane (FCE 24304), a new steroidal aromatase inhibitor. The Journal of Steroid Biochemistry and Molecular Biology, 43(1-3), 137-143.
5. Lønning, P. E. (2001). Exemestane: a review of its clinical efficacy and safety. The breast, 10(3), 198-208.
6. Buzdar, A. (2000). Exemestane in advanced breast cancer. Anti-cancer drugs, 11(8), 609-616.
7. Fallowfield, L. J., Bliss, J. M., Porter, L. S., Price, M. H., Snowdon, C. F., Jones, S. E., ... & Hall, E. (2006). Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. Journal of Clinical Oncology, 24(6), 910-917.